Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Dyslipidemia

  Free Subscription


Articles published in Metabolism

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    September 2024
  1. JEONG JH, Kim YG, Han KD, Roh SY, et al
    Association of fatty liver index with sudden cardiac arrest in young adults.
    Metabolism. 2024;158:155981.
    PubMed     Abstract available


  2. DANPANICHKUL P, Suparan K, Dutta P, Kaeosri C, et al
    Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
    Metabolism. 2024;158:155958.
    PubMed     Abstract available


    July 2024
  3. HAGVE M, Pereira SL, Walker DK, Engelen MPKJ, et al
    Statin treatment reduces leucine turnover, but does not affect endogenous production of beta-hydroxy-beta-methylbutyrate (HMB).
    Metabolism. 2024;156:155920.
    PubMed     Abstract available


    June 2024
  4. EZHILARASAN D
    Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha/gamma agonist for managing metabolic NAFLD.
    Metabolism. 2024;155:155912.
    PubMed     Abstract available


    April 2024
  5. ZELJKOVIC A, Vekic J, Stefanovic A
    Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
    Metabolism. 2024;156:155919.
    PubMed     Abstract available


    November 2023
  6. ZUO F, Wang Y, Xu X, Ding R, et al
    CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
    PubMed     Abstract available


    July 2023
  7. WANG YD, Wu LL, Mai YN, Wang K, et al
    miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
    PubMed     Abstract available


    December 2022
  8. ZHANG J, Wu Y, Zhang J, Zhang R, et al
    ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
    Metabolism. 2022 Dec 12:155377. doi: 10.1016/j.metabol.2022.155377.
    PubMed     Abstract available


  9. HUANGFU G, Jaltotage B, Pang J, Lan NSR, et al
    Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia.
    Metabolism. 2022;139:155370.
    PubMed     Abstract available


    November 2022
  10. YE J, Zhuang X, Li X, Gong X, et al
    Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation.
    Metabolism. 2022;136:155294.
    PubMed     Abstract available


    October 2022
  11. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
    Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
    Metabolism. 2022;137:155329.
    PubMed     Abstract available


    September 2022
  12. TRICO D, Mengozzi A, Baldi S, Bizzotto R, et al
    Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.
    Metabolism. 2022;134:155247.
    PubMed     Abstract available


    July 2022
  13. BOUZONI E, Perakakis N, Connelly MA, Angelidi AM, et al
    PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
    Metabolism. 2022 Jul 9:155265. doi: 10.1016/j.metabol.2022.155265.
    PubMed     Abstract available


    January 2022
  14. NEGI CK, Babica P, Bajard L, Bienertova-Vasku J, et al
    Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.
    Metabolism. 2022;126:154925.
    PubMed     Abstract available


    December 2021
  15. BULLO M, Papandreou C, Garcia-Gavilan J, Ruiz-Canela M, et al
    Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure.
    Metabolism. 2021;125:154915.
    PubMed     Abstract available


  16. HANA CA, Tran LV, Molzer C, Mullner E, et al
    Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
    Metabolism. 2021;125:154913.
    PubMed     Abstract available


    November 2021
  17. YING Q, Chan DC, Barrett PHR, Watts GF, et al
    Unravelling lipoprotein metabolism with stable isotopes: tracing the flow.
    Metabolism. 2021;124:154887.
    PubMed     Abstract available


    July 2021
  18. LIU S, Wang J, Wu S, Niu J, et al
    The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
    Metabolism. 2021;120:154779.
    PubMed     Abstract available


    June 2021
  19. PICHE ME, Clavel MA, Auclair A, Rodriguez-Flores M, et al
    Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization.
    Metabolism. 2021;119:154773.
    PubMed     Abstract available


    May 2021
  20. ALI S, Malloci M, Safiedeen Z, Soleti R, et al
    LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4.
    Metabolism. 2021;118:154727.
    PubMed     Abstract available


    March 2021
  21. XU X, Dong Y, Ma N, Kong W, et al
    MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
    PubMed     Abstract available


  22. ONG KL, McClelland RL, Allison MA, Cushman M, et al
    Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.
    Metabolism. 2021;116:154706.
    PubMed     Abstract available


    February 2021
  23. NAKATSU Y, Yamamotoya T, Okumura M, Ishii T, et al
    Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis.
    Metabolism. 2021;115:154459.
    PubMed     Abstract available


  24. PICHE ME, Tardif I, Auclair A, Poirier P, et al
    Effects of bariatric surgery on lipid-lipoprotein profile.
    Metabolism. 2021;115:154441.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.